Shopping Cart 0
Cart Subtotal
USD 0

Metabolic Disorders Drugs Global Market Report 2019

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4000

Access to Printed Report; No Soft Copy
Print Option: N/A
Copy Option: N/A
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 4000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 6000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

CD-Rom
USD 4000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 8000

Details

The metabolic disorders drugs market consists of sales of metabolic disorders drugs and related services by entities (organizations, sole traders and partnerships) that produce metabolic disorders drugs to treat metabolic diseases. This industry includes establishments that produce drugs such as insulin, pramlintide and other drugs to treat diabetes, anti-thyroid drugs to treat hyperthyroidism, and other drugs to treat pituitary gland, adrenal gland and parathyroid gland disorders.

North America was the largest region in the global metabolic disorders drugs market, accounting for 42% of the market in 2018. Western Europe was the second largest region accounting for 24% of the global metabolic disorders drugs market. Africa was the smallest region in the global metabolic disorders drugs market.

Administration (FDA) has approved various enzyme replacement therapies for the treatment of metabolic disorders. Enzyme replacement therapy is used for treatment of rare genetic disorders through purified human, animal or recombinant enzymes. In December 2015, the FDA approved an enzyme replacement therapy Kanuma that can be used to treat adult and pediatric patients suffering from lysosomal acid lipase deficiency, a metabolic disorder that causes problems with the breakdown and use of fats and cholesterol in the body. Similarly, in October 2015, FDA had announced the approval of Strensiq, a drug that can be used for the treatment of perinatal, infantile and juvenile-onset hypophosphatasia, which is a metabolic disorder affecting multiple body systems.

READ MORE

Table Of Content

Scope

1. Executive Summary

2. Report Structure

3. Metabolic Disorders Drugs Market Characteristics

3.1. Market Definition

3.2. Key Segmentations

4. Metabolic Disorders Drugs Market Product Analysis

4.1. Leading Products/ Services

4.2. Key Features and Differentiators

4.3. Development Products

5. Metabolic Disorders Drugs Market Supply Chain

5.1. Supply Chain

5.2. Distribution

5.3. End Customers

6. Metabolic Disorders Drugs Market Customer Information

6.1. Customer Preferences

6.2. End Use Market Size and Growth

7. Metabolic Disorders Drugs Market Trends And Strategies

8. Metabolic Disorders Drugs Market Size And Growth

8.1. Market Size

8.2. Historic Market Growth, Value (USD Billion)

8.2.1. Drivers Of The Market

8.2.2. Restraints On The Market

8.3. Forecast Market Growth, Value (USD Billion)

8.3.1. Drivers Of The Market

8.3.2. Restraints On The Market

9. Metabolic Disorders Drugs Market Regional Analysis

9.1. Global Metabolic Disorders Drugs Market, 2018, By Region, Value (USD Billion)

9.2. Global Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Region

9.3. Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Region

10. Metabolic Disorders Drugs Market Segmentation

10.1. Global Metabolic Disorders Drugs Market, Segmentation By Type, 2014-2022, Value (USD Billion)

10.1.1. Anti Diabetics drugs

10.1.2. Anti-Thyroid drugs

10.1.3. Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)

11. Metabolic Disorders Drugs Market Metrics

11.1. Metabolic Disorders Drugs Market Size, Percentage Of GDP, 2014-2022, Global

11.2. Per Capita Average Metabolic Disorders Drugs Market Expenditure, 2014-2022, Global

12. Asia-Pacific Metabolic Disorders Drugs Market

12.1. Asia-Pacific Metabolic Disorders Drugs Market Overview

12.2. Asia-Pacific, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

12.3. Asia-Pacific, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

12.4. Asia-Pacific, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

12.5. Asia-Pacific, Metabolic Disorders Drugs Market Metrics

12.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Asia-Pacific Countries

12.6. Asia-Pacific Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7. Asia-Pacific Metabolic Disorders Drugs Market: Country Analysis

12.7.1. China Metabolic Disorders Drugs Market

12.7.1.1. China Metabolic Disorders Drugs Market Overview

12.7.1.2. China Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.1.3. China Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

12.7.1.4. China Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7.2. Australia Metabolic Disorders Drugs Market

12.7.2.1. Australia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.2.2. Australia Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

12.7.2.3. Australia Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7.3. Hong Kong Metabolic Disorders Drugs Market

12.7.3.1. Hong Kong Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.4. India Metabolic Disorders Drugs Market

12.7.4.1. India Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.4.2. India Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

12.7.4.3. India Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7.5. Indonesia Metabolic Disorders Drugs Market

12.7.5.1. Indonesia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.6. Japan Metabolic Disorders Drugs Market

12.7.6.1. Japan Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.6.2. Japan Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

12.7.6.3. Japan Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7.7. Malaysia Metabolic Disorders Drugs Market

12.7.7.1. Malaysia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.8. New Zealand Metabolic Disorders Drugs Market

12.7.8.1. New Zealand Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.9. Philippines Metabolic Disorders Drugs Market

12.7.9.1. Philippines Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.10. Singapore Metabolic Disorders Drugs Market

12.7.10.1. Singapore Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.11. South Korea Metabolic Disorders Drugs Market

12.7.11.1. South Korea Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.12. Thailand Metabolic Disorders Drugs Market

12.7.12.1. Thailand Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.13. Vietnam Metabolic Disorders Drugs Market

12.7.13.1. Vietnam Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13. Western Europe Metabolic Disorders Drugs Market

13.1. Western Europe Metabolic Disorders Drugs Market Overview

13.2. Western Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

13.3. Western Europe, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

13.4. Western Europe, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

13.5. Western Europe, Metabolic Disorders Drugs Market Metrics

13.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Western Europe Countries

13.6. Western Europe Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7. Western Europe Metabolic Disorders Drugs Market: Country Analysis

13.7.1. Austria Metabolic Disorders Drugs Market

13.7.1.1. Austria Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.2. Belgium Metabolic Disorders Drugs Market

13.7.2.1. Belgium Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.3. Denmark Metabolic Disorders Drugs Market

13.7.3.1. Denmark Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.4. Finland Metabolic Disorders Drugs Market

13.7.4.1. Finland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.5. France Metabolic Disorders Drugs Market

13.7.5.1. France Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.5.2. France Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

13.7.5.3. France Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7.6. Germany Metabolic Disorders Drugs Market

13.7.6.1. Germany Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.6.2. Germany Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

13.7.6.3. Germany Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7.7. Ireland Metabolic Disorders Drugs Market

13.7.7.1. Ireland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.8. Italy Metabolic Disorders Drugs Market

13.7.8.1. Italy Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.8.2. Italy Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

13.7.8.3. Italy Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7.9. Netherlands Metabolic Disorders Drugs Market

13.7.9.1. Netherlands Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.10. Norway Metabolic Disorders Drugs Market

13.7.10.1. Norway Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.11. Portugal Metabolic Disorders Drugs Market

13.7.11.1. Portugal Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.12. Spain Metabolic Disorders Drugs Market

13.7.12.1. Spain Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.12.2. Spain Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

13.7.12.3. Spain Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7.13. Sweden Metabolic Disorders Drugs Market

13.7.13.1. Sweden Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.14. Switzerland Metabolic Disorders Drugs Market

13.7.14.1. Switzerland Metabolic Disorders Drugs Market2013-2022, Value (USD Billion)

13.7.15. UK Metabolic Disorders Drugs Market

13.7.15.1. UK Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.15.2. UK Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

13.7.15.3. UK Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

14. Eastern Europe Metabolic Disorders Drugs Market

14.1. Eastern Europe Metabolic Disorders Drugs Market Overview

14.2. Eastern Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

14.3. Eastern Europe, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

14.4. Eastern Europe, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

14.5. Eastern Europe, Metabolic Disorders Drugs Market Metrics

14.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Eastern Europe Countries

14.6. Eastern Europe Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

14.7. Eastern Europe Metabolic Disorders Drugs Market: Country Analysis

14.7.1. Czech Republic Metabolic Disorders Drugs Market,

14.7.1.1. Czech Republic Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

14.7.2. Poland Metabolic Disorders Drugs Market

14.7.2.1. Poland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

14.7.3. Romania Metabolic Disorders Drugs Market

14.7.3.1. Romania Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

14.7.4. Russia Metabolic Disorders Drugs Market

14.7.4.1. Russia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

14.7.4.2. Russia Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

14.7.4.3. Russia Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

15. North America Metabolic Disorders Drugs Market

15.1. North America Metabolic Disorders Drugs Market Overview

15.2. North America, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

15.3. North America, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

15.4. North America, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

15.5. North America, Metabolic Disorders Drugs Market Metrics

15.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, North America Countries

15.6. North America Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

15.7. North America Metabolic Disorders Drugs Market: Country Analysis

15.7.1. Canada Metabolic Disorders Drugs Market

15.7.1.1. Canada Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

15.7.2. Mexico Metabolic Disorders Drugs Market

15.7.2.1. Mexico Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

15.7.3. USA Metabolic Disorders Drugs Market

15.7.3.1. USA Metabolic Disorders Drugs Market Overview

15.7.3.2. USA Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

15.7.3.3. USA Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

15.7.3.4. USA Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

16. South America Metabolic Disorders Drugs Market

16.1. South America Metabolic Disorders Drugs Market Overview

16.2. South America, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

16.3. South America, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

16.4. South America, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

16.5. South America, Metabolic Disorders Drugs Market Metrics

16.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, South America Countries

16.6. South America Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

16.7. South America Metabolic Disorders Drugs Market: Country Analysis

16.7.1. Argentina Metabolic Disorders Drugs Market

16.7.1.1. Argentina Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

16.7.2. Brazil Metabolic Disorders Drugs Market

16.7.2.1. Brazil Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

16.7.2.2. Brazil Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

16.7.2.3. Brazil Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

16.7.3. Chile Metabolic Disorders Drugs Market

16.7.3.1. Chile Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

16.7.4. Colombia Metabolic Disorders Drugs Market

16.7.4.1. Colombia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

16.7.5. Peru Metabolic Disorders Drugs Market

16.7.5.1. Peru Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

16.7.6. Venezuela Metabolic Disorders Drugs Market

16.7.6.1. Venezuela Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

17. Middle East Metabolic Disorders Drugs Market

17.1. Middle East Metabolic Disorders Drugs Market Overview

17.2. Middle East, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

17.3. Middle East, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

17.4. Middle East, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

17.5. Middle East, Metabolic Disorders Drugs Market Metrics

17.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Middle East Countries

17.6. Middle East Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

17.7. Middle East Metabolic Disorders Drugs Market: Country Analysis

17.7.1. Saudi Arabia Metabolic Disorders Drugs Market

17.7.1.1. Saudi Arabia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

17.7.2. Israel Metabolic Disorders Drugs Market

17.7.2.1. Israel Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

17.7.3. Turkey Metabolic Disorders Drugs Market

17.7.3.1. Turkey Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

17.7.4. UAE Metabolic Disorders Drugs Market

17.7.4.1. UAE Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

18. Africa Metabolic Disorders Drugs Market

18.1. Africa Metabolic Disorders Drugs Market Overview

18.2. Africa, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

18.3. Africa, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

18.4. Africa, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

18.5. Africa, Metabolic Disorders Drugs Market Metrics

18.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Africa Countries

18.6. Africa Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

18.7. Africa Metabolic Disorders Drugs Market: Country Analysis

18.7.1. Egypt Metabolic Disorders Drugs Market

18.7.1.1. Egypt Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

18.7.2. Nigeria Metabolic Disorders Drugs Market

18.7.2.1. Nigeria Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

18.7.3. South Africa Metabolic Disorders Drugs Market

18.7.3.1. South Africa Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

19. Metabolic Disorders Drugs Market Competitive Landscape

19.1. Competitive Market Overview

19.2. Market Shares

19.3. Company Profiles

19.3.1. Sanofi S.A

19.3.1.1. Company Overview

19.3.1.2. Company Metabolic Disorders Drugs Market Structure And Strategy

19.3.1.3. Company Metabolic Disorders Drugs Market Products And Services

19.3.1.4. Financial Performance

19.3.2. Novo Nordisk A/S

19.3.2.1. Company Overview

19.3.2.2. Company Metabolic Disorders Drugs Market Structure And Strategy

19.3.2.3. Company Metabolic Disorders Drugs Market Products And Services

19.3.2.4. Financial Performance

19.3.3. AstraZeneca Plc

19.3.3.1. Company Overview

19.3.3.2. Company Metabolic Disorders Drugs Market Structure And Strategy

19.3.3.3. Company Metabolic Disorders Drugs Market Products And Services

19.3.3.4. Financial Performance

19.3.4. Johnson & Johnson

19.3.4.1. Company Overview

19.3.4.2. Company Metabolic Disorders Drugs Market Structure And Strategy

19.3.4.3. Company Metabolic Disorders Drugs Market Products And Services

19.3.4.4. Financial Performance

19.3.5. Merck & Co

19.3.5.1. Company Overview

19.3.5.2. Company Metabolic Disorders Drugs Market Structure And Strategy

19.3.5.3. Company Metabolic Disorders Drugs Market Products And Services

19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Metabolic Disorders Drugs Market

21. Market Background: Pharmaceutical Drugs Market

21.1. Pharmaceutical Drugs Market Characteristics

21.2. Pharmaceutical Drugs Market Historic and Forecast, 2014-2022 Growth, by segment, Value (USD Billion), Global

21.3. Global Pharmaceutical Drugs Market, 2018, By Region, Value (USD Billion)

21.4. Global Pharmaceutical Drugs Market, 2014-2022, Historic And Forecast, By Region

21.5. Global Pharmaceutical Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

22. Recommendations

22.1. Global Metabolic Disorders Drugs Market In 2022- Growth Countries

22.2. Global Metabolic Disorders Drugs Market In 2022- Growth Segments

22.3. Global Metabolic Disorders Drugs Market In 2022- Growth Strategies

23. Appendix

23.1. NAICS Definitions Of Industry Covered In This Report

23.2. Abbreviations

23.3. Currencies

23.4. Research Inquiries

23.5. The Business Research Company

24. Copyright And Disclaimer


List Of Figure

Figure 1: Historic Market Growth, Value (USD Billion)

Figure 2: Forecast Market Growth, Value (USD Billion)

Figure 3: Global Metabolic Disorders Drugs Market, 2018, By Region, Value (USD Billion)

Figure 4: Global Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Region

Figure 5: Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Region

Figure 6: Global Metabolic Disorders Drugs Market, Segmentation By Type, 2014-2022, Value (USD Billion)

Figure 7: Metabolic Disorders Drugs Market Size, Percentage Of GDP, 2014-2022, Global

Figure 8: Per Capita Average Metabolic Disorders Drugs Market Expenditure, 2014-2022, Global

Figure 9: Asia-Pacific, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Figure 10: Asia-Pacific, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 11: Asia-Pacific, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 12: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Asia-Pacific Countries

Figure 13: Asia-Pacific Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 14: China Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 15: China Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 16: China Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 17: Australia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 18: Australia Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 19: Australia Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 20: Hong Kong Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 21: India Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 22: India Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 23: India Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 24: Indonesia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 25: Japan Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 26: Japan Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 27: Japan Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 28: Malaysia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 29: New Zealand Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 30: Philippines Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 31: Singapore Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 32: South Korea Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 33: Thailand Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 34: Vietnam Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 35: Western Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Figure 36: Western Europe, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 37: Western Europe, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 38: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Western Europe Countries

Figure 39: Western Europe Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 40: Austria Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 41: Belgium Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 42: Denmark Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 43: Finland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 44: France Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 45: France Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 46: France Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 47: Germany Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 48: Germany Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 49: Germany Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 50: Ireland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 51: Italy Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 52: Italy Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 53: Italy Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 54: Netherlands Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 55: Norway Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 56: Portugal Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 57: Spain Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 58: Spain Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 59: Spain Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 60: Sweden Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 61: Switzerland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 62: UK Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 63: UK Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 64: UK Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 65: Eastern Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Figure 66: Eastern Europe, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 67: Eastern Europe, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 68: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Eastern Europe Countries

Figure 69: Eastern Europe Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 70: Czech Republic Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 71: Poland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 72: Romania Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 73: Russia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 74: Russia Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 75: Russia Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 76: North America, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Figure 77: North America, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 78: North America, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 79: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, North America Countries

Figure 80: North America Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 81: Canada Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 82: Mexico Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 83: USA Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 84: USA Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 85: USA Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 86: South America, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Figure 87: South America, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 88: South America, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 89: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, South America Countries

Figure 90: South America Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 91: Argentina Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 92: Brazil Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 93: Brazil Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 94: Brazil Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 95: Chile Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 96: Colombia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 97: Peru Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 98: Venezuela Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 99: Middle East, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Figure 100: Middle East, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 101: Middle East, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 102: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Middle East Countries

Figure 103: Middle East Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 104: Saudi Arabia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 105: Israel Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 106: Turkey Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 107: UAE Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 108: Africa, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Figure 109: Africa, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 110: Africa, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 111: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Africa Countries

Figure 112: Africa Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 113: Egypt Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 114: Nigeria Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 115: South Africa Metabolic Disorders Drugs Market2014-2022, Value (USD Billion)

Figure 116: Sanofi S.A Financial Performance

Figure 117: Novo Nordisk A/S Financial Performance

Figure 118: AstraZeneca Plc Financial Performance

Figure 119: Johnson & Johnson Financial Performance

Figure 120: Merck & Co Financial Performance

Figure 121: Pharmaceutical Drugs Market Historic and Forecast, 2014-2022, Growth, By Segment, Value (USD Billion), Global

Figure 122: Global Pharmaceutical Drugs Market, 2018, By Region, Value (USD Billion)

Figure 123: Global Pharmaceutical Drugs Market, 2014-2022, Historic And Forecast, By Region

Figure 124: Global Pharmaceutical Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 125: Global Metabolic Disorders Drugs Market In 2022- Growth Countries

Figure 126: Global Metabolic Disorders Drugs Market In 2022- Growth Segments

Figure 127: Global Metabolic Disorders Drugs Market In 2022- Growth Strategies


List Of Table

Table 1: Historic Market Growth, Value (USD Billion)

Table 2: Forecast Market Growth, Value (USD Billion)

Table 3: Global Metabolic Disorders Drugs Market, 2018, By Region, Value (USD Billion)

Table 4: Global Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Region

Table 5: Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Region

Table 6: Global Metabolic Disorders Drugs Market, Segmentation By Type, 2014-2022, Value (USD Billion)

Table 7: Metabolic Disorders Drugs Market Size, Percentage Of GDP, 2014-2022, Global

Table 8: Per Capita Average Metabolic Disorders Drugs Market Expenditure, 2014-2022, Global

Table 9: Asia-Pacific, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Table 10: Asia-Pacific, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 11: Asia-Pacific, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 12: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Asia-Pacific Countries

Table 13: Asia-Pacific Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 14: China Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 15: China Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 16: China Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 17: Australia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 18: Australia Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 19: Australia Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 20: Hong Kong Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 21: India Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 22: India Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 23: India Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 24: Indonesia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 25: Japan Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 26: Japan Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 27: Japan Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 28: Malaysia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 29: New Zealand Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 30: Philippines Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 31: Singapore Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 32: South Korea Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 33: Thailand Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 34: Vietnam Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 35: Western Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Table 36: Western Europe, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 37: Western Europe, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 38: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Western Europe Countries

Table 39: Western Europe Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 40: Austria Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 41: Belgium Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 42: Denmark Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 43: Finland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 44: France Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 45: France Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 46: France Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 47: Germany Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 48: Germany Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 49: Germany Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 50: Ireland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 51: Italy Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 52: Italy Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 53: Italy Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 54: Netherlands Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 55: Norway Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 56: Portugal Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 57: Spain Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 58: Spain Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 59: Spain Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 60: Sweden Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 61: Switzerland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 62: UK Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 63: UK Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 64: UK Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 65: Eastern Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Table 66: Eastern Europe, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 67: Eastern Europe, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 68: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Eastern Europe Countries

Table 69: Eastern Europe Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 70: Czech Republic Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 71: Poland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 72: Romania Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 73: Russia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 74: Russia Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 75: Russia Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 76: North America, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Table 77: North America, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 78: North America, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 79: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, North America Countries

Table 80: North America Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 81: Canada Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 82: Mexico Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 83: USA Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 84: USA Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 85: USA Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 86: South America, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Table 87: South America, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 88: South America, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 89: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, South America Countries

Table 90: South America Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 91: Argentina Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 92: Brazil Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 93: Brazil Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 94: Brazil Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 95: Chile Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 96: Colombia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 97: Peru Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 98: Venezuela Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 99: Middle East, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Table 100: Middle East, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 101: Middle East, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 102: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Middle East Countries

Table 103: Middle East Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 104: Saudi Arabia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 105: Israel Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 106: Turkey Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 107: UAE Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 108: Africa, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Table 109: Africa, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 110: Africa, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 111: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Africa Countries

Table 112: Africa Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 113: Egypt Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 114: Nigeria Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 115: South Africa Metabolic Disorders Drugs Market2014-2022, Value (USD Billion)

Table 116: Sanofi S.A Financial Performance

Table 117: Novo Nordisk A/S Financial Performance

Table 118: AstraZeneca Plc Financial Performance

Table 119: Johnson & Johnson Financial Performance

Table 120: Merck & Co Financial Performance

Table 121: Pharmaceutical Drugs Market Historic and Forecast, 2014-2022, Growth, By Segment, Value (USD Billion), Global

Table 122: Global Pharmaceutical Drugs Market, 2018, By Region, Value (USD Billion)

Table 123: Global Pharmaceutical Drugs Market, 2014-2022, Historic And Forecast, By Region

Table 124: Global Pharmaceutical Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 125: Global Metabolic Disorders Drugs Market In 2022- Growth Countries

Table 126: Global Metabolic Disorders Drugs Market In 2022- Growth Segments

Table 127: Global Metabolic Disorders Drugs Market In 2022- Growth Strategies

Licence Rights

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Anti Diabetics drugs, Anti-Thyroid drugs, Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)


Companies

Sanofi S.A, Novo Nordisk A/S, AstraZeneca Plc, Johnson & Johnson, Merck & Co

Company Profile

Company Profile Title

The metabolic disorders drugs market consists of sales of metabolic disorders drugs and related services by entities (organizations, sole traders and partnerships) that produce metabolic disorders drugs to treat metabolic diseases. This industry includes establishments that produce drugs such as insulin, pramlintide and other drugs to treat diabetes, anti-thyroid drugs to treat hyperthyroidism, and other drugs to treat pituitary gland, adrenal gland and parathyroid gland disorders.

North America was the largest region in the global metabolic disorders drugs market, accounting for 42% of the market in 2018. Western Europe was the second largest region accounting for 24% of the global metabolic disorders drugs market. Africa was the smallest region in the global metabolic disorders drugs market.

Administration (FDA) has approved various enzyme replacement therapies for the treatment of metabolic disorders. Enzyme replacement therapy is used for treatment of rare genetic disorders through purified human, animal or recombinant enzymes. In December 2015, the FDA approved an enzyme replacement therapy Kanuma that can be used to treat adult and pediatric patients suffering from lysosomal acid lipase deficiency, a metabolic disorder that causes problems with the breakdown and use of fats and cholesterol in the body. Similarly, in October 2015, FDA had announced the approval of Strensiq, a drug that can be used for the treatment of perinatal, infantile and juvenile-onset hypophosphatasia, which is a metabolic disorder affecting multiple body systems.

READ MORE

Scope

1. Executive Summary

2. Report Structure

3. Metabolic Disorders Drugs Market Characteristics

3.1. Market Definition

3.2. Key Segmentations

4. Metabolic Disorders Drugs Market Product Analysis

4.1. Leading Products/ Services

4.2. Key Features and Differentiators

4.3. Development Products

5. Metabolic Disorders Drugs Market Supply Chain

5.1. Supply Chain

5.2. Distribution

5.3. End Customers

6. Metabolic Disorders Drugs Market Customer Information

6.1. Customer Preferences

6.2. End Use Market Size and Growth

7. Metabolic Disorders Drugs Market Trends And Strategies

8. Metabolic Disorders Drugs Market Size And Growth

8.1. Market Size

8.2. Historic Market Growth, Value (USD Billion)

8.2.1. Drivers Of The Market

8.2.2. Restraints On The Market

8.3. Forecast Market Growth, Value (USD Billion)

8.3.1. Drivers Of The Market

8.3.2. Restraints On The Market

9. Metabolic Disorders Drugs Market Regional Analysis

9.1. Global Metabolic Disorders Drugs Market, 2018, By Region, Value (USD Billion)

9.2. Global Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Region

9.3. Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Region

10. Metabolic Disorders Drugs Market Segmentation

10.1. Global Metabolic Disorders Drugs Market, Segmentation By Type, 2014-2022, Value (USD Billion)

10.1.1. Anti Diabetics drugs

10.1.2. Anti-Thyroid drugs

10.1.3. Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)

11. Metabolic Disorders Drugs Market Metrics

11.1. Metabolic Disorders Drugs Market Size, Percentage Of GDP, 2014-2022, Global

11.2. Per Capita Average Metabolic Disorders Drugs Market Expenditure, 2014-2022, Global

12. Asia-Pacific Metabolic Disorders Drugs Market

12.1. Asia-Pacific Metabolic Disorders Drugs Market Overview

12.2. Asia-Pacific, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

12.3. Asia-Pacific, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

12.4. Asia-Pacific, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

12.5. Asia-Pacific, Metabolic Disorders Drugs Market Metrics

12.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Asia-Pacific Countries

12.6. Asia-Pacific Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7. Asia-Pacific Metabolic Disorders Drugs Market: Country Analysis

12.7.1. China Metabolic Disorders Drugs Market

12.7.1.1. China Metabolic Disorders Drugs Market Overview

12.7.1.2. China Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.1.3. China Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

12.7.1.4. China Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7.2. Australia Metabolic Disorders Drugs Market

12.7.2.1. Australia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.2.2. Australia Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

12.7.2.3. Australia Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7.3. Hong Kong Metabolic Disorders Drugs Market

12.7.3.1. Hong Kong Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.4. India Metabolic Disorders Drugs Market

12.7.4.1. India Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.4.2. India Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

12.7.4.3. India Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7.5. Indonesia Metabolic Disorders Drugs Market

12.7.5.1. Indonesia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.6. Japan Metabolic Disorders Drugs Market

12.7.6.1. Japan Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.6.2. Japan Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

12.7.6.3. Japan Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7.7. Malaysia Metabolic Disorders Drugs Market

12.7.7.1. Malaysia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.8. New Zealand Metabolic Disorders Drugs Market

12.7.8.1. New Zealand Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.9. Philippines Metabolic Disorders Drugs Market

12.7.9.1. Philippines Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.10. Singapore Metabolic Disorders Drugs Market

12.7.10.1. Singapore Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.11. South Korea Metabolic Disorders Drugs Market

12.7.11.1. South Korea Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.12. Thailand Metabolic Disorders Drugs Market

12.7.12.1. Thailand Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

12.7.13. Vietnam Metabolic Disorders Drugs Market

12.7.13.1. Vietnam Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13. Western Europe Metabolic Disorders Drugs Market

13.1. Western Europe Metabolic Disorders Drugs Market Overview

13.2. Western Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

13.3. Western Europe, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

13.4. Western Europe, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

13.5. Western Europe, Metabolic Disorders Drugs Market Metrics

13.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Western Europe Countries

13.6. Western Europe Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7. Western Europe Metabolic Disorders Drugs Market: Country Analysis

13.7.1. Austria Metabolic Disorders Drugs Market

13.7.1.1. Austria Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.2. Belgium Metabolic Disorders Drugs Market

13.7.2.1. Belgium Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.3. Denmark Metabolic Disorders Drugs Market

13.7.3.1. Denmark Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.4. Finland Metabolic Disorders Drugs Market

13.7.4.1. Finland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.5. France Metabolic Disorders Drugs Market

13.7.5.1. France Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.5.2. France Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

13.7.5.3. France Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7.6. Germany Metabolic Disorders Drugs Market

13.7.6.1. Germany Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.6.2. Germany Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

13.7.6.3. Germany Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7.7. Ireland Metabolic Disorders Drugs Market

13.7.7.1. Ireland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.8. Italy Metabolic Disorders Drugs Market

13.7.8.1. Italy Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.8.2. Italy Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

13.7.8.3. Italy Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7.9. Netherlands Metabolic Disorders Drugs Market

13.7.9.1. Netherlands Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.10. Norway Metabolic Disorders Drugs Market

13.7.10.1. Norway Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.11. Portugal Metabolic Disorders Drugs Market

13.7.11.1. Portugal Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.12. Spain Metabolic Disorders Drugs Market

13.7.12.1. Spain Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.12.2. Spain Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

13.7.12.3. Spain Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7.13. Sweden Metabolic Disorders Drugs Market

13.7.13.1. Sweden Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.14. Switzerland Metabolic Disorders Drugs Market

13.7.14.1. Switzerland Metabolic Disorders Drugs Market2013-2022, Value (USD Billion)

13.7.15. UK Metabolic Disorders Drugs Market

13.7.15.1. UK Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

13.7.15.2. UK Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

13.7.15.3. UK Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

14. Eastern Europe Metabolic Disorders Drugs Market

14.1. Eastern Europe Metabolic Disorders Drugs Market Overview

14.2. Eastern Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

14.3. Eastern Europe, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

14.4. Eastern Europe, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

14.5. Eastern Europe, Metabolic Disorders Drugs Market Metrics

14.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Eastern Europe Countries

14.6. Eastern Europe Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

14.7. Eastern Europe Metabolic Disorders Drugs Market: Country Analysis

14.7.1. Czech Republic Metabolic Disorders Drugs Market,

14.7.1.1. Czech Republic Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

14.7.2. Poland Metabolic Disorders Drugs Market

14.7.2.1. Poland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

14.7.3. Romania Metabolic Disorders Drugs Market

14.7.3.1. Romania Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

14.7.4. Russia Metabolic Disorders Drugs Market

14.7.4.1. Russia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

14.7.4.2. Russia Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

14.7.4.3. Russia Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

15. North America Metabolic Disorders Drugs Market

15.1. North America Metabolic Disorders Drugs Market Overview

15.2. North America, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

15.3. North America, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

15.4. North America, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

15.5. North America, Metabolic Disorders Drugs Market Metrics

15.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, North America Countries

15.6. North America Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

15.7. North America Metabolic Disorders Drugs Market: Country Analysis

15.7.1. Canada Metabolic Disorders Drugs Market

15.7.1.1. Canada Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

15.7.2. Mexico Metabolic Disorders Drugs Market

15.7.2.1. Mexico Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

15.7.3. USA Metabolic Disorders Drugs Market

15.7.3.1. USA Metabolic Disorders Drugs Market Overview

15.7.3.2. USA Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

15.7.3.3. USA Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

15.7.3.4. USA Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

16. South America Metabolic Disorders Drugs Market

16.1. South America Metabolic Disorders Drugs Market Overview

16.2. South America, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

16.3. South America, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

16.4. South America, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

16.5. South America, Metabolic Disorders Drugs Market Metrics

16.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, South America Countries

16.6. South America Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

16.7. South America Metabolic Disorders Drugs Market: Country Analysis

16.7.1. Argentina Metabolic Disorders Drugs Market

16.7.1.1. Argentina Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

16.7.2. Brazil Metabolic Disorders Drugs Market

16.7.2.1. Brazil Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

16.7.2.2. Brazil Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

16.7.2.3. Brazil Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

16.7.3. Chile Metabolic Disorders Drugs Market

16.7.3.1. Chile Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

16.7.4. Colombia Metabolic Disorders Drugs Market

16.7.4.1. Colombia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

16.7.5. Peru Metabolic Disorders Drugs Market

16.7.5.1. Peru Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

16.7.6. Venezuela Metabolic Disorders Drugs Market

16.7.6.1. Venezuela Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

17. Middle East Metabolic Disorders Drugs Market

17.1. Middle East Metabolic Disorders Drugs Market Overview

17.2. Middle East, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

17.3. Middle East, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

17.4. Middle East, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

17.5. Middle East, Metabolic Disorders Drugs Market Metrics

17.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Middle East Countries

17.6. Middle East Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

17.7. Middle East Metabolic Disorders Drugs Market: Country Analysis

17.7.1. Saudi Arabia Metabolic Disorders Drugs Market

17.7.1.1. Saudi Arabia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

17.7.2. Israel Metabolic Disorders Drugs Market

17.7.2.1. Israel Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

17.7.3. Turkey Metabolic Disorders Drugs Market

17.7.3.1. Turkey Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

17.7.4. UAE Metabolic Disorders Drugs Market

17.7.4.1. UAE Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

18. Africa Metabolic Disorders Drugs Market

18.1. Africa Metabolic Disorders Drugs Market Overview

18.2. Africa, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

18.3. Africa, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

18.4. Africa, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

18.5. Africa, Metabolic Disorders Drugs Market Metrics

18.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Africa Countries

18.6. Africa Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

18.7. Africa Metabolic Disorders Drugs Market: Country Analysis

18.7.1. Egypt Metabolic Disorders Drugs Market

18.7.1.1. Egypt Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

18.7.2. Nigeria Metabolic Disorders Drugs Market

18.7.2.1. Nigeria Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

18.7.3. South Africa Metabolic Disorders Drugs Market

18.7.3.1. South Africa Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

19. Metabolic Disorders Drugs Market Competitive Landscape

19.1. Competitive Market Overview

19.2. Market Shares

19.3. Company Profiles

19.3.1. Sanofi S.A

19.3.1.1. Company Overview

19.3.1.2. Company Metabolic Disorders Drugs Market Structure And Strategy

19.3.1.3. Company Metabolic Disorders Drugs Market Products And Services

19.3.1.4. Financial Performance

19.3.2. Novo Nordisk A/S

19.3.2.1. Company Overview

19.3.2.2. Company Metabolic Disorders Drugs Market Structure And Strategy

19.3.2.3. Company Metabolic Disorders Drugs Market Products And Services

19.3.2.4. Financial Performance

19.3.3. AstraZeneca Plc

19.3.3.1. Company Overview

19.3.3.2. Company Metabolic Disorders Drugs Market Structure And Strategy

19.3.3.3. Company Metabolic Disorders Drugs Market Products And Services

19.3.3.4. Financial Performance

19.3.4. Johnson & Johnson

19.3.4.1. Company Overview

19.3.4.2. Company Metabolic Disorders Drugs Market Structure And Strategy

19.3.4.3. Company Metabolic Disorders Drugs Market Products And Services

19.3.4.4. Financial Performance

19.3.5. Merck & Co

19.3.5.1. Company Overview

19.3.5.2. Company Metabolic Disorders Drugs Market Structure And Strategy

19.3.5.3. Company Metabolic Disorders Drugs Market Products And Services

19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Metabolic Disorders Drugs Market

21. Market Background: Pharmaceutical Drugs Market

21.1. Pharmaceutical Drugs Market Characteristics

21.2. Pharmaceutical Drugs Market Historic and Forecast, 2014-2022 Growth, by segment, Value (USD Billion), Global

21.3. Global Pharmaceutical Drugs Market, 2018, By Region, Value (USD Billion)

21.4. Global Pharmaceutical Drugs Market, 2014-2022, Historic And Forecast, By Region

21.5. Global Pharmaceutical Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

22. Recommendations

22.1. Global Metabolic Disorders Drugs Market In 2022- Growth Countries

22.2. Global Metabolic Disorders Drugs Market In 2022- Growth Segments

22.3. Global Metabolic Disorders Drugs Market In 2022- Growth Strategies

23. Appendix

23.1. NAICS Definitions Of Industry Covered In This Report

23.2. Abbreviations

23.3. Currencies

23.4. Research Inquiries

23.5. The Business Research Company

24. Copyright And Disclaimer


List Of Figure

Figure 1: Historic Market Growth, Value (USD Billion)

Figure 2: Forecast Market Growth, Value (USD Billion)

Figure 3: Global Metabolic Disorders Drugs Market, 2018, By Region, Value (USD Billion)

Figure 4: Global Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Region

Figure 5: Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Region

Figure 6: Global Metabolic Disorders Drugs Market, Segmentation By Type, 2014-2022, Value (USD Billion)

Figure 7: Metabolic Disorders Drugs Market Size, Percentage Of GDP, 2014-2022, Global

Figure 8: Per Capita Average Metabolic Disorders Drugs Market Expenditure, 2014-2022, Global

Figure 9: Asia-Pacific, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Figure 10: Asia-Pacific, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 11: Asia-Pacific, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 12: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Asia-Pacific Countries

Figure 13: Asia-Pacific Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 14: China Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 15: China Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 16: China Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 17: Australia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 18: Australia Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 19: Australia Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 20: Hong Kong Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 21: India Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 22: India Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 23: India Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 24: Indonesia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 25: Japan Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 26: Japan Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 27: Japan Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 28: Malaysia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 29: New Zealand Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 30: Philippines Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 31: Singapore Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 32: South Korea Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 33: Thailand Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 34: Vietnam Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 35: Western Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Figure 36: Western Europe, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 37: Western Europe, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 38: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Western Europe Countries

Figure 39: Western Europe Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 40: Austria Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 41: Belgium Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 42: Denmark Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 43: Finland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 44: France Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 45: France Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 46: France Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 47: Germany Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 48: Germany Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 49: Germany Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 50: Ireland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 51: Italy Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 52: Italy Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 53: Italy Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 54: Netherlands Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 55: Norway Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 56: Portugal Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 57: Spain Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 58: Spain Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 59: Spain Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 60: Sweden Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 61: Switzerland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 62: UK Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 63: UK Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 64: UK Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 65: Eastern Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Figure 66: Eastern Europe, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 67: Eastern Europe, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 68: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Eastern Europe Countries

Figure 69: Eastern Europe Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 70: Czech Republic Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 71: Poland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 72: Romania Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 73: Russia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 74: Russia Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 75: Russia Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 76: North America, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Figure 77: North America, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 78: North America, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 79: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, North America Countries

Figure 80: North America Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 81: Canada Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 82: Mexico Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 83: USA Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 84: USA Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 85: USA Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 86: South America, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Figure 87: South America, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 88: South America, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 89: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, South America Countries

Figure 90: South America Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 91: Argentina Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 92: Brazil Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 93: Brazil Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Figure 94: Brazil Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 95: Chile Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 96: Colombia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 97: Peru Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 98: Venezuela Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 99: Middle East, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Figure 100: Middle East, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 101: Middle East, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 102: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Middle East Countries

Figure 103: Middle East Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 104: Saudi Arabia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 105: Israel Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 106: Turkey Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 107: UAE Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 108: Africa, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Figure 109: Africa, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 110: Africa, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 111: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Africa Countries

Figure 112: Africa Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 113: Egypt Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 114: Nigeria Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Figure 115: South Africa Metabolic Disorders Drugs Market2014-2022, Value (USD Billion)

Figure 116: Sanofi S.A Financial Performance

Figure 117: Novo Nordisk A/S Financial Performance

Figure 118: AstraZeneca Plc Financial Performance

Figure 119: Johnson & Johnson Financial Performance

Figure 120: Merck & Co Financial Performance

Figure 121: Pharmaceutical Drugs Market Historic and Forecast, 2014-2022, Growth, By Segment, Value (USD Billion), Global

Figure 122: Global Pharmaceutical Drugs Market, 2018, By Region, Value (USD Billion)

Figure 123: Global Pharmaceutical Drugs Market, 2014-2022, Historic And Forecast, By Region

Figure 124: Global Pharmaceutical Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 125: Global Metabolic Disorders Drugs Market In 2022- Growth Countries

Figure 126: Global Metabolic Disorders Drugs Market In 2022- Growth Segments

Figure 127: Global Metabolic Disorders Drugs Market In 2022- Growth Strategies


List Of Table

Table 1: Historic Market Growth, Value (USD Billion)

Table 2: Forecast Market Growth, Value (USD Billion)

Table 3: Global Metabolic Disorders Drugs Market, 2018, By Region, Value (USD Billion)

Table 4: Global Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Region

Table 5: Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Region

Table 6: Global Metabolic Disorders Drugs Market, Segmentation By Type, 2014-2022, Value (USD Billion)

Table 7: Metabolic Disorders Drugs Market Size, Percentage Of GDP, 2014-2022, Global

Table 8: Per Capita Average Metabolic Disorders Drugs Market Expenditure, 2014-2022, Global

Table 9: Asia-Pacific, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Table 10: Asia-Pacific, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 11: Asia-Pacific, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 12: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Asia-Pacific Countries

Table 13: Asia-Pacific Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 14: China Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 15: China Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 16: China Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 17: Australia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 18: Australia Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 19: Australia Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 20: Hong Kong Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 21: India Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 22: India Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 23: India Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 24: Indonesia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 25: Japan Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 26: Japan Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 27: Japan Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 28: Malaysia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 29: New Zealand Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 30: Philippines Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 31: Singapore Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 32: South Korea Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 33: Thailand Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 34: Vietnam Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 35: Western Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Table 36: Western Europe, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 37: Western Europe, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 38: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Western Europe Countries

Table 39: Western Europe Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 40: Austria Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 41: Belgium Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 42: Denmark Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 43: Finland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 44: France Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 45: France Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 46: France Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 47: Germany Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 48: Germany Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 49: Germany Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 50: Ireland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 51: Italy Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 52: Italy Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 53: Italy Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 54: Netherlands Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 55: Norway Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 56: Portugal Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 57: Spain Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 58: Spain Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 59: Spain Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 60: Sweden Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 61: Switzerland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 62: UK Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 63: UK Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 64: UK Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 65: Eastern Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Table 66: Eastern Europe, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 67: Eastern Europe, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 68: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Eastern Europe Countries

Table 69: Eastern Europe Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 70: Czech Republic Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 71: Poland Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 72: Romania Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 73: Russia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 74: Russia Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 75: Russia Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 76: North America, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Table 77: North America, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 78: North America, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 79: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, North America Countries

Table 80: North America Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 81: Canada Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 82: Mexico Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 83: USA Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 84: USA Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 85: USA Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 86: South America, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Table 87: South America, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 88: South America, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 89: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, South America Countries

Table 90: South America Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 91: Argentina Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 92: Brazil Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 93: Brazil Metabolic Disorders Drugs Market, 2014-2022, Volume (Million Units)

Table 94: Brazil Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 95: Chile Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 96: Colombia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 97: Peru Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 98: Venezuela Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 99: Middle East, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Table 100: Middle East, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 101: Middle East, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 102: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Middle East Countries

Table 103: Middle East Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 104: Saudi Arabia Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 105: Israel Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 106: Turkey Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 107: UAE Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 108: Africa, Metabolic Disorders Drugs Market, 2018, By Country, Value (USD Billion)

Table 109: Africa, Metabolic Disorders Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 110: Africa, Metabolic Disorders Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 111: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014-2022, Africa Countries

Table 112: Africa Metabolic Disorders Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 113: Egypt Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 114: Nigeria Metabolic Disorders Drugs Market, 2014-2022, Value (USD Billion)

Table 115: South Africa Metabolic Disorders Drugs Market2014-2022, Value (USD Billion)

Table 116: Sanofi S.A Financial Performance

Table 117: Novo Nordisk A/S Financial Performance

Table 118: AstraZeneca Plc Financial Performance

Table 119: Johnson & Johnson Financial Performance

Table 120: Merck & Co Financial Performance

Table 121: Pharmaceutical Drugs Market Historic and Forecast, 2014-2022, Growth, By Segment, Value (USD Billion), Global

Table 122: Global Pharmaceutical Drugs Market, 2018, By Region, Value (USD Billion)

Table 123: Global Pharmaceutical Drugs Market, 2014-2022, Historic And Forecast, By Region

Table 124: Global Pharmaceutical Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 125: Global Metabolic Disorders Drugs Market In 2022- Growth Countries

Table 126: Global Metabolic Disorders Drugs Market In 2022- Growth Segments

Table 127: Global Metabolic Disorders Drugs Market In 2022- Growth Strategies

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)
To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Anti Diabetics drugs, Anti-Thyroid drugs, Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)


Companies

Sanofi S.A, Novo Nordisk A/S, AstraZeneca Plc, Johnson & Johnson, Merck & Co